Targets to retard the progression of diabetic nephropathy

Kidney Int. 2005 Oct;68(4):1439-45. doi: 10.1111/j.1523-1755.2005.00555.x.

Authors

Mark E Cooper¹, Karin Jandeleit-Dahm, Merlin C Thomas

Affiliation

¹ Danielle Alberti Memorial Centre for Diabetes Complications, Baker Medical Research Institute, Melbourne, Victoria, Australia. Mark.Cooper@baker.edu.au

PMID: 16164619
DOI: 10.1111/j.1523-1755.2005.00555.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Diabetes Mellitus, Type 1 / physiopathology
Diabetes Mellitus, Type 1 / therapy*
Diabetes Mellitus, Type 2 / physiopathology
Diabetes Mellitus, Type 2 / therapy*
Diabetic Nephropathies / physiopathology
Diabetic Nephropathies / therapy*
Disease Progression
Humans